Abstract

FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes

Author(s): Steven J Sherry, Abdel K Tahari, Sahar Mirpour, Andrew Colucci and Rathan M Subramaniam

Paraneoplastic neurologic syndromes (PNS) are a rare, heterogeneous group of complications associated with malignancy, unrelated to direct tumor invasion or metastasis, that may be immune-mediated. The aim of this article is to provide an overview of PNS and outline the value of 2-deoxy-2-[18F]fluoro-D-glucose PET/CT in the evaluation of patients with a PNS. 2-deoxy-2-18F-fluoro-D-glucose PET/CT is valuable to identify or exclude an occult malignancy in patients with suspected paraneoplastic syndromes.